ArticleIBRO neuroscience reports2025
An approach to screen susceptible rats and efficacy of an antidepressive treatment after chronic stress.
Article in IBRO neuroscience reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic stress during life has been considered a risk factor for the development of psychiatric illness in humans. Chronic unpredictable stress battery (CUSB) is an animal model to study depression through stress exposition in rodents. CUSB induces depression and anxiety behavioral markers that could be modulated with fluoxetine an antidepressant treatment. However, it is well known that not all subjects develop depression-like behaviors or do not respond to antidepressant treatments. The way to screen these individual differences in susceptibility to stress or the efficacy of antidepressant therapy in depression models is not well studied. Here we show that saccharine consumption, immobility and time spent in the center of the area could be useful as behavioral markers for screening susceptibility to stress and depression, also we show that fluoxetine treatment had different efficacy depending on the age when the stress occurred. First, we found that after CUSB (during adolescence, adulthood, or both) rodents show depression and anxiety profiles. Second, we found that fluoxetine (10 mg/kg) could recover depression but no anxiety profile in all the groups exposed to stress. Finally, we use the machine learning clustering method (k-means), to classify the subjects in all groups based on the individual effects modulated by stress exposure and antidepressant treatment to find the ratio of stress effects and pharmacological efficacy. Using altered behaviors as classifiers, we found three possible clusters, (1) Without alterations, (2) Moderated anxiety and depression profile (3) Serious anxiety and depression profile, suggesting two groups of susceptible animals with different intensities of altered behavior. Also, fluoxetine could change the ratio of rats previously classified in groups 2 or 3, showing the beneficial effects of antidepressant treatment. Our results demonstrate that CUSB has different consequences even in subjects that experienced the same stress protocol. Also, fluoxetine has different efficacy in recovering behavior associated with the age of exposure to stress. Finally, we suggest k-means as an easy and useful method to apply in susceptible rodent studies of depression and to study the individual efficacy of antidepressant treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.